SEC 13F Intelligence

Neumeier Poma Investment Counsel LLC / MED

Neumeier Poma Investment Counsel LLC’s Medifast Inc Position

Does Neumeier Poma Investment Counsel LLC own Medifast Inc (MED)? Not currently — the last reported position was 207.2K shares worth $37M in Q2 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$37M
Q2 2022
Shares
207.2K
% of Portfolio
+2.93%
Quarters Held
4
position exited

Position History MED

Reported value by quarter
Q3 ’21: $17MQ3 ’21Q4 ’21: $29MQ4 ’21Q1 ’22: $30MQ1 ’22Q2 ’22: $37MQ2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2022207.2K$37M+2.93%
Q1 2022173.7K$30M+1.99%
Q4 2021139.3K$29M+1.63%
Q3 202187.0K$17M+1.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neumeier Poma Investment Counsel LLC’s full portfolio or all institutional holders of MED.